Royalty Pharma plc (RPRX)
| Previous close | 37.50 |
| Open | 37.57 |
| Bid | 37.53 x 800 |
| Ask | 37.57 x 900 |
| Day's range | 37.48 - 37.71 |
| 52-week range | 34.80 - 53.23 |
| Volume | 59,707 |
| Avg. volume | 2,338,767 |
| Market cap | 22.878B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 30.51 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.68 (1.82%) |
| Ex-dividend date | 18 Nov 2021 |
| 1y target est | N/A |
- GlobeNewswire
Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter of 2021 financial results on Wednesday, November 10, 2021 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information The conference call can be accessed live over the phone for U.S. callers by dialing (833) 519-1253 or for international callers by dialing +1
- GlobeNewswire
Royalty Pharma Declares Fourth-Quarter 2021 Dividend
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordinary share. The dividend will be paid on December 15, 2021, to shareholders of record at the close of business on November 19, 2021. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical
- GlobeNewswire
Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September: Citi’s 16th Annual BioPharma Virtual Conference on Thursday, September 9 at 10:40 a.m. EDTMorgan Stanley’s 19th Annual Global Healthcare Conference on Tuesday, September 14 at 11:00 a.m. EDT The webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/
